RS49768B - Proces za pripremu zofenopril kalcijumove soli - Google Patents
Proces za pripremu zofenopril kalcijumove soliInfo
- Publication number
- RS49768B RS49768B YUP-75/01A YU7501A RS49768B RS 49768 B RS49768 B RS 49768B YU 7501 A YU7501 A YU 7501A RS 49768 B RS49768 B RS 49768B
- Authority
- RS
- Serbia
- Prior art keywords
- zofenopril
- potassium salt
- calcium salts
- polymorph
- zofenopril calcium
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- NSYUKKYYVFVMST-LETVYOFWSA-L zofenopril calcium Chemical class [Ca+2].C([C@@H](C)C(=O)N1[C@@H](C[C@@H](C1)SC=1C=CC=CC=1)C([O-])=O)SC(=O)C1=CC=CC=C1.C([C@@H](C)C(=O)N1[C@@H](C[C@@H](C1)SC=1C=CC=CC=1)C([O-])=O)SC(=O)C1=CC=CC=C1 NSYUKKYYVFVMST-LETVYOFWSA-L 0.000 title abstract 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 abstract 3
- IAIDUHCBNLFXEF-MNEFBYGVSA-N zofenopril Chemical compound C([C@@H](C)C(=O)N1[C@@H](C[C@@H](C1)SC=1C=CC=CC=1)C(O)=O)SC(=O)C1=CC=CC=C1 IAIDUHCBNLFXEF-MNEFBYGVSA-N 0.000 abstract 3
- 239000007864 aqueous solution Substances 0.000 abstract 2
- 238000006243 chemical reaction Methods 0.000 abstract 2
- 229960002769 zofenopril Drugs 0.000 abstract 2
- XXNAGGDFBCTLQA-DHTOPLTISA-N (2r,4r)-4-phenylsulfanylpyrrolidine-2-carboxylic acid;hydrochloride Chemical compound Cl.C1N[C@@H](C(=O)O)C[C@H]1SC1=CC=CC=C1 XXNAGGDFBCTLQA-DHTOPLTISA-N 0.000 abstract 1
- BCAYPPFBOJCRPN-MRVPVSSYSA-N (2s)-3-benzoylsulfanyl-2-methylpropanoic acid Chemical compound OC(=O)[C@H](C)CSC(=O)C1=CC=CC=C1 BCAYPPFBOJCRPN-MRVPVSSYSA-N 0.000 abstract 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 230000001476 alcoholic effect Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000001110 calcium chloride Substances 0.000 abstract 1
- 229910001628 calcium chloride Inorganic materials 0.000 abstract 1
- 235000011148 calcium chloride Nutrition 0.000 abstract 1
- 159000000007 calcium salts Chemical class 0.000 abstract 1
- 238000010899 nucleation Methods 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
- C01F11/00—Compounds of calcium, strontium, or barium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Geology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Proces za pripremu polimorfa A od zofenopril kalcijum soli u gotovo potpuno čistoj formi koji sadrži: a) Reakciju hlorida S(-)-3-benzoiltio-2-metilpropanske kiseline sa cis-4-feniltio-L-prolinom u vodi na pH u rasponu od 9-9.5 i nastanak zofenoprila u kiseloj formi; b) Salifikaciju kiselog zofenoprila sa soli kalijuma u alkoholnom rastvoru i izdvajanje nastale soli kalijuma; c) Pretvaranje soli kalijuma u soli kalcijuma dodavanjem vodenog rastvora zofenopril kalijum soli u vodeni rastvor CaCl2 na temperaturi 70-90° C sa simulatnim zasejavanjem da se obezbedi taloženje polimorfa A. Prijava sadrži još 14 zahteva.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1998MI001833A IT1301993B1 (it) | 1998-08-04 | 1998-08-04 | Processo per la preparazione di zofenopril sale di calcio. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| YU7501A YU7501A (sh) | 2005-06-10 |
| RS49768B true RS49768B (sr) | 2008-06-05 |
Family
ID=11380611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YUP-75/01A RS49768B (sr) | 1998-08-04 | 1999-07-30 | Proces za pripremu zofenopril kalcijumove soli |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US6521760B1 (sr) |
| EP (1) | EP1102745B1 (sr) |
| JP (1) | JP2002522417A (sr) |
| KR (1) | KR100593428B1 (sr) |
| CN (1) | CN1146538C (sr) |
| AT (1) | ATE266635T1 (sr) |
| AU (1) | AU5372299A (sr) |
| BG (1) | BG65022B1 (sr) |
| BR (1) | BR9912842A (sr) |
| CA (1) | CA2339283C (sr) |
| CU (1) | CU23171A3 (sr) |
| CZ (1) | CZ301908B6 (sr) |
| DE (1) | DE69917282T2 (sr) |
| DK (1) | DK1102745T3 (sr) |
| EA (1) | EA003454B1 (sr) |
| EE (1) | EE04798B1 (sr) |
| ES (1) | ES2221417T3 (sr) |
| HK (1) | HK1039616B (sr) |
| HR (1) | HRP20010083B1 (sr) |
| HU (1) | HU227557B1 (sr) |
| IL (1) | IL141222A0 (sr) |
| IT (1) | IT1301993B1 (sr) |
| NO (1) | NO319773B1 (sr) |
| PL (1) | PL193828B1 (sr) |
| PT (1) | PT1102745E (sr) |
| RS (1) | RS49768B (sr) |
| SI (1) | SI1102745T1 (sr) |
| SK (1) | SK285527B6 (sr) |
| TR (1) | TR200100272T2 (sr) |
| UA (1) | UA65628C2 (sr) |
| WO (1) | WO2000007984A1 (sr) |
| ZA (1) | ZA200100907B (sr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2560502T3 (es) * | 2005-07-01 | 2016-02-19 | Generics [Uk] Limited | Zofenopril calcio en forma de polimorfo C |
| EA012845B1 (ru) * | 2005-12-09 | 2009-12-30 | Менарини Интернэшнл Оперейшнс Люксембург С. А. | Фармацевтическая композиция, содержащая зофеноприл и hctz, для лечения гипертензии |
| SI2041083T1 (sl) * | 2006-05-26 | 2015-02-27 | Generics (Uk) Limited | Metode za pripravo zofenopril kalcija |
| GB0715626D0 (en) * | 2007-08-10 | 2007-09-19 | Generics Uk Ltd | Crystalline form of zofenopril calcium |
| AU2009219892B2 (en) * | 2008-02-27 | 2014-08-07 | Generics [Uk] Limited | Novel crystalline forms |
| US8853421B2 (en) | 2008-02-27 | 2014-10-07 | Generics [Uk] Limited | Crystalline forms of zofenopril calcium |
| EP2389360A4 (en) * | 2009-01-23 | 2013-01-16 | Glenmark Generics Ltd | METHOD FOR PRODUCING ZOFENOPRIL AND PHARMACEUTICAL ACCEPTIC SALTS THEREFOR |
| SI23949A (sl) | 2011-12-19 | 2013-06-28 | Silverstone Pharma | Nove kristalne soli zofenoprila, postopek za njihovo dobivanje in njihova uporaba v terapiji |
| CN104138359B (zh) * | 2013-05-06 | 2016-03-02 | 扬子江药业集团上海海尼药业有限公司 | 佐芬普利钙片的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4105776A (en) * | 1976-06-21 | 1978-08-08 | E. R. Squibb & Sons, Inc. | Proline derivatives and related compounds |
| US4154935A (en) * | 1978-02-21 | 1979-05-15 | E. R. Squibb & Sons, Inc. | Halogen substituted mercaptoacylamino acids |
| US4316906A (en) * | 1978-08-11 | 1982-02-23 | E. R. Squibb & Sons, Inc. | Mercaptoacyl derivatives of substituted prolines |
-
1998
- 1998-08-04 IT IT1998MI001833A patent/IT1301993B1/it active IP Right Grant
-
1999
- 1999-07-30 KR KR1020017001379A patent/KR100593428B1/ko not_active IP Right Cessation
- 1999-07-30 RS YUP-75/01A patent/RS49768B/sr unknown
- 1999-07-30 ES ES99939416T patent/ES2221417T3/es not_active Expired - Lifetime
- 1999-07-30 AU AU53722/99A patent/AU5372299A/en not_active Abandoned
- 1999-07-30 SK SK163-2001A patent/SK285527B6/sk not_active IP Right Cessation
- 1999-07-30 PT PT99939416T patent/PT1102745E/pt unknown
- 1999-07-30 IL IL14122299A patent/IL141222A0/xx not_active IP Right Cessation
- 1999-07-30 EA EA200100095A patent/EA003454B1/ru not_active IP Right Cessation
- 1999-07-30 JP JP2000563619A patent/JP2002522417A/ja active Pending
- 1999-07-30 EP EP99939416A patent/EP1102745B1/en not_active Expired - Lifetime
- 1999-07-30 UA UA2001010590A patent/UA65628C2/uk unknown
- 1999-07-30 US US09/762,054 patent/US6521760B1/en not_active Expired - Fee Related
- 1999-07-30 BR BR9912842-0A patent/BR9912842A/pt not_active Application Discontinuation
- 1999-07-30 CN CNB998105171A patent/CN1146538C/zh not_active Expired - Lifetime
- 1999-07-30 WO PCT/EP1999/005461 patent/WO2000007984A1/en active IP Right Grant
- 1999-07-30 CZ CZ20010408A patent/CZ301908B6/cs not_active IP Right Cessation
- 1999-07-30 PL PL99345814A patent/PL193828B1/pl unknown
- 1999-07-30 EE EEP200100065A patent/EE04798B1/xx unknown
- 1999-07-30 AT AT99939416T patent/ATE266635T1/de active
- 1999-07-30 DK DK99939416T patent/DK1102745T3/da active
- 1999-07-30 CA CA002339283A patent/CA2339283C/en not_active Expired - Lifetime
- 1999-07-30 SI SI9930575T patent/SI1102745T1/xx unknown
- 1999-07-30 HU HU0103826A patent/HU227557B1/hu unknown
- 1999-07-30 TR TR2001/00272T patent/TR200100272T2/xx unknown
- 1999-07-30 DE DE69917282T patent/DE69917282T2/de not_active Expired - Lifetime
-
2001
- 2001-01-24 BG BG105176A patent/BG65022B1/bg unknown
- 2001-02-01 ZA ZA200100907A patent/ZA200100907B/en unknown
- 2001-02-01 CU CU20010032A patent/CU23171A3/es unknown
- 2001-02-01 NO NO20010552A patent/NO319773B1/no not_active IP Right Cessation
- 2001-02-01 HR HR20010083A patent/HRP20010083B1/xx not_active IP Right Cessation
-
2002
- 2002-02-21 HK HK02101248.6A patent/HK1039616B/zh not_active IP Right Cessation
- 2002-05-28 US US10/155,129 patent/US6515012B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4401677A (en) | Enkephalinase inhibitors | |
| KR890700590A (ko) | 폴린산의 분리방법 | |
| RS49768B (sr) | Proces za pripremu zofenopril kalcijumove soli | |
| EA200500318A1 (ru) | Антипирен и способ его получения | |
| TNSN05089A1 (fr) | Nouveau procede de synthese industriel du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates | |
| EA200100184A1 (ru) | Новые гидратные формы алендроната натрия, способы их получения и фармацевтические композиции | |
| MA26100A1 (fr) | Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis(carboxymethyl) amino]-3-carboxymethyl-4-cyano-2-thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates. | |
| CA2425615A1 (en) | Process for the purification of gabapentin using a strong cation exchange resin | |
| DE60316010D1 (de) | Neue kristalline hydrate des natriumsalzes der 3-pyridyl-1-hydroxyethyliden-1-bisphosphonsäure | |
| JPH10237030A (ja) | 分岐鎖アミノ酸の精製法 | |
| AU5513499A (en) | Method for producing sodium chloride crystals | |
| EA200501734A1 (ru) | Способ получения (4-гидрокси-6-оксотетрагидропиран-2-ил)ацетонитрила и его производных | |
| EA200300614A1 (ru) | Кристаллические соли металл-глюкозамин сульфата и способы их приготовления | |
| RU2239599C2 (ru) | Неслеживающиеся кристаллы хлорида натрия, способ их получения и их применение в электролитическом процессе | |
| FR2547593B1 (fr) | Procede d'obtention de saccharose phosphorylase, saccharose phosphorylase obtenue par le procede et application a la synthese de l'acide glucose-1-phosphorique et de ses sels | |
| SU1065389A1 (ru) | Дигидроксотетрафосфат кальци дл использовани в качестве удобрени | |
| JPS55108405A (en) | Aqueous solution of modified polyacrylamide cation, use thereof and production thereof | |
| KR960004365A (ko) | 5'-리보뉴클레오티드칼슘의 제조방법 | |
| RU1791436C (ru) | Способ уменьшени слеживаемости калийного удобрени | |
| RU2002106956A (ru) | Способ получения трехзамещенного фосфата магния | |
| Griffith | Amino acid sulfoximines: α-Ethylmethionine sulfoximine | |
| JPS55133340A (en) | Separation of alpha-amino acid from iminodicarboxylic acid | |
| YU38901A (sh) | Etanolat azitromicina, procesi proizvodnje i njegov farmaceutski sastav | |
| RU97120562A (ru) | Способ выделения натриевой соли оксациллина | |
| JPS60172297A (ja) | コバルトイオンの少ない光学活性アミノ酸の製造法 |